Clene Inc.

Name: Clene Inc. standardized financial statements, quarterly
Creator: Listed

CLNNNasdaqCIK 1822791HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$90.0k, Q2 FY2026

Operating income−$5.3m, Q2 FY2026

Net income−$13.4m, Q2 FY2026

Clene Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1
Cost of revenue	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Research and development	$m	6.0	6.7	5.9	4.2	4.5	5.6	1.5	3.5	3.5	5.5	0.3	3.5
Operating income	$m	(9.5)	(9.9)	(9.2)	(7.4)	(7.8)	(8.7)	(4.1)	(5.9)	(5.6)	(7.5)	(2.1)	(5.3)
Interest expense	$m	1.2	1.2	1.2	1.3	1.0	0.5	0.6	0.7	0.6	0.7	0.8	0.7
Income tax	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income	$m	(2.4)	(10.2)	(11.1)	(6.8)	(8.0)	(13.5)	(0.8)	(7.4)	(8.8)	(9.2)	(8.1)	(13.4)
Diluted EPS	$ per share	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Basic EPS	$ per share	(0.38)	not reported	(1.73)	(1.06)	(1.22)	not reported	(0.09)	(0.78)	(0.85)	not reported	(0.69)	(1.08)

Balance sheet

Cash and equivalents$9.7m, Q2 FY2026

Long-term debt$17.6m, Q2 FY2026

Shareholders' equity−$24.8m, Q2 FY2026

Clene Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	42.1	28.8	21.7	21.7	14.6	12.2	9.8	7.3	7.9	5.2	5.9	9.7
Current assets	$m	46.4	38.9	32.1	27.9	19.7	16.2	14.7	12.0	12.7	9.0	13.0	14.9
Total assets	$m	60.4	52.3	45.1	40.3	31.6	27.3	25.3	22.1	22.3	18.1	21.7	23.0
Current liabilities	$m	15.3	25.3	26.2	28.1	23.8	10.3	10.8	7.6	8.3	10.8	6.7	4.9
Total liabilities	$m	39.0	39.0	40.8	40.8	35.7	36.2	30.3	30.7	34.7	35.7	40.5	47.8
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	16.6	16.5	17.9	17.8	17.7	17.6
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	21.4	13.4	4.3	(0.5)	(4.1)	(8.9)	(5.0)	(8.6)	(12.4)	(17.6)	(18.8)	(24.8)

Cash flow

Operating cash flow−$2.6m, Q2 FY2026

Capital expenditure$28.0k, Q4 FY2025

Clene Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(6,760)	(7,172)	(7,082)	(6,356)	(3,023)	(4,865)	(5,011)	(4,744)	(3,992)	(4,799)	(4,528)	(2,588)
Capital expenditure	$k	48.0	43.0	11.0	2.0	1.0	1.0	0.0	0.0	11.0	28.0	not reported	not reported

Diluted shares (weighted)63.51m, Q3 FY2022

Clene Inc., shares, quarterly
Line item	Unit	period not labelled2020-09-30	Q2 FY20212021-06-30	Q3 FY20212021-09-30	Q2 FY20222022-06-30	Q3 FY20222022-09-30
Diluted shares (weighted)	m shares	17.4	61.2	70.0	63.3	63.5

Shares outstanding: 12.85m at Aug 11, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.